1 completed, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Hyperoxalemia: new trials by email Literature Review of Hyperoxalemia trials Research Report on Hyperoxalemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lumasiran in Hyperoxalaemic Patients on Haemodialysis Lumasiran, 0.9% Sodium Chloride (placebo) - Haemodialysis, Chronic Kidney Disease Requiring Chronic Dialysis | Phase 2 | Unknown | Charite University, Berlin, Germany | 50 | 2024-04-14 | 2024-08-21 |
| Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia ALLN-177 - Enteric Hyperoxaluria, Primary Hyperoxaluria | Phase 2 | Completed | Allena Pharmaceuticals | 15 | 2018-07-17 | 2020-12-30 |
Cardiovascular Diseases (1) · Hyperoxaluria, Primary (1) · Kidney Calculi (1)
Calculi (1) · Carbohydrate Metabolism, Inborn Errors (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1) · Hyperoxaluria (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Metabolic Diseases (1) · Metabolism, Inborn Errors (1) · Nephrolithiasis (1) · Nutritional and Metabolic Diseases (1) · Pathological Conditions, Anatomical (1) · Pathological Conditions, Signs and Symptoms (1)
Sodium Chloride (1) · lumasiran (1) · oxalate decarboxylase (1) · reloxaliase (1)
Allena Pharmaceuticals (1) · Charite University, Berlin, Germany (1)
Germany (2) · United Kingdom (1) · United States (1)
David Clark, MD (1) · Felix Knauf, MD (1)
2017 (1)